Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin + Azacitidine + Venetoclax in Newly Diagnosed AML
NCT06841952Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Feb 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
tretinoin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT06841952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841952.